[Ip-health] Man gets three years probation, no jail time, for importing counterfeit drugs into USA

Jamie Love james.love at keionline.org
Thu May 31 10:47:12 PDT 2012


Despite very tough laws on the books in the US for counterfeiting,
which include possible life sentences for some offenses, and the very
aggressive federal PR campaign against counterfeit drugs, the US is
not always that tough on the trade in counterfeit drugs.  In this
recent case, Curtis Henry was sentenced to three years probation, and
spent less time in jail than many do for selling marijuana.

Jamie


http://www.ice.gov/news/releases/1205/120518rochester.htm

MAY 18, 2012ROCHESTER, NY

Upstate New York man sentenced for importing counterfeit pharmaceuticals

ROCHESTER, N.Y. – An upstate New York man was sentenced Wednesday to
three years probation and ordered to pay restitution in the amount of
$13,377 for importing counterfeit Viagra and Cialis tablets into the
United States. This investigation was conducted by U.S. Immigration
and Customs Enforcement's (ICE) Homeland Security Investigations (HSI)
and the U.S. Food and Drug Administration (FDA).

According to court documents, between January and June 2011, Curtis
Henry, 53, of Rochester, ordered more than 700 counterfeit Viagra and
Cialis tablets from a source in China. After receiving the counterfeit
pharmaceutical tablets, Henry sold them in Rochester. Henry was
sentenced by U.S. District Judge Charles J. Siragusa after he pleaded
guilty to the charge Nov. 2, 2011.

"Counterfeit drugs pose a serious threat to public health and safety,
and those who engage in this illicit practice have no concern for the
well-being of people's lives," said James Spero, special agent in
charge of HSI Buffalo, N.Y. "People who purchase drugs should never
have to put their lives at risk because the product is fake, unsafe or
untested. Homeland Security Investigations and our law enforcement
partners in New York will continue to work diligently to make sure
counterfeit products stay off of our streets."

"This investigation again demonstrates the commitment of FDA's Office
of Criminal Investigations to aggressively pursue those who distribute
counterfeit prescription drugs and who greedily place at risk the
health and safety of consumers to line their pockets," said Mark
Dragonetti, special agent in charge of the FDA, Office of Criminal
Investigations, New York Field Office. "I would like to commend the
U.S. attorney's office and our joint law enforcement partners at
Homeland Security Investigations in our continued efforts in combating
counterfeit drugs."

As the largest investigative arm of the U.S. Department of Homeland
Security, HSI plays a leading role in targeting criminal organizations
responsible for producing, smuggling and distributing counterfeit
products. HSI focuses not only on keeping counterfeit products off the
streets, but also on dismantling the criminal organizations behind
such illicit activity.

HSI manages the National Intellectual Property Rights Coordination
Center (IPR Center) in Washington, D.C. The IPR Center is one of the
U.S. government's key weapons in the fight against criminal
counterfeiting and piracy. As a task force, the IPR Center uses the
expertise of its 20 member agencies to share information, develop
initiatives, coordinate enforcement actions and conduct investigations
related to IP (Intellectual Property) theft. Through this strategic
interagency partnership, the IPR Center protects the public's health
and safety, the U.S. economy and the war fighters.

To report IP theft or to learn more about the IPR Center, visit
www.IPRCenter.gov.

Assistant U.S. Attorney Bradley E. Tyler prosecuted this case on
behalf of the U.S. government.

------------------------------

for more examples of ICE press releases on counterfeit drug cases,
see:  http://www.keionline.org/node/1427, Recent ICE Press releases
mentioning counterfeit and pharmaceutical

-- 
James Love.  Knowledge Ecology International
http://www.keionline.org, +1.202.332.2670, US Mobile: +1.202.361.3040,
Geneva Mobile: +41.76.413.6584, efax: +1.888.245.3140.
twitter.com/jamie_love




More information about the Ip-health mailing list